First-of-its-Kind probiotic trial aims to tame autoimmune disease
NCT ID NCT06297213
Summary
This early-stage study is testing a new oral probiotic called R-2487 in people with Sjogren's Syndrome, an autoimmune disease. The main goal is to see if the probiotic is safe and well-tolerated. Researchers will also check if it helps reduce disease activity and improves patients' quality of life by measuring symptoms and inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.